ArticleBMC geriatrics2025
Development and validation of a predictive model for sarcopenia risk in older Chinese adults based on key factors.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The risk prediction models for sarcopenia in older adults: a systematic review and critical appraisal.Frontiers in public health · 2026Pooled it
- Longitudinal association between sleep duration and fall risk in middle-aged and older adults: A multiple mediation pathways analysis.Sleep medicine: X · 2026Article
- The prevalence and influencing factors of dynapenia among middle-aged and elderly individuals with knee osteoarthritis: a cross-sectional analysis.BMC musculoskeletal disorders · 2026Article
- Risk prediction of sarcopenia in a large health checkup population: development and validation of a dynamic online nomogram.Frontiers in public health · 2026Article
- Hierarchical Evaluation of Predictive Models for Confirmed Sarcopenia: Discrimination, Calibration, and Clinical Applicability in a Cross-Sectional Study of Older Adults.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSarcopenia, characterized by progressive loss of skeletal muscle mass and function, is a growing public health concern, particularly among aging populations in China. However, comprehensive predictive models for sarcopenia risk remain scarce. This study aims to develop and validate an accurate, interpretable predictive model for sarcopenia risk in elderly Chinese adults, identifying independent risk factors and offering insights for targeted interventions.
methodsThis cohort study utilized data from the China Health and Retirement Longitudinal Study (CHARLS). Participants aged 60 years and older, free of sarcopenia at baseline in 2011, were followed through 2013. After excluding individuals with missing data, extreme values, or confounding conditions (e.g., cancer, disabilities), 2,197 participants were included. Sarcopenia was diagnosed according to the 2019 Asian Working Group for Sarcopenia (AWGS) criteria, which assess appendicular skeletal muscle mass, muscle strength, and physical performance. A range of sociodemographic, health, lifestyle, psychological, and biochemical factors were analyzed using multivariable logistic regression. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration, and decision curve analysis.
resultsOver a two-year period, the incidence of sarcopenia was 10.29%, with higher rates observed in women (13.20%) compared to men (7.99%). Independent risk factors included older age, lower BMI, female, memory-related diseases, arthritis or rheumatism, shorter sleep duration, and lower education levels. The logistic regression model demonstrated robust performance with an AUC of 0.849 (95% CI: 0.821-0.878) and consistent calibration. Restricted cubic spline analyses revealed protective effects of BMI (21.3-26.0) and sleep duration (5-8 h). The model provides clinical utility, emphasizing modifiable risk factors and enhancing interpretability.
conclusionsThis study offers a practical and interpretable predictive model for sarcopenia, highlighting key modifiable risk factors such as BMI and sleep duration. The findings underscore the critical need for evidence-based, individualized prevention strategies and a multidisciplinary approach to mitigate sarcopenia in aging populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.